Pioneering Biopharmaceutical Manufacturing in Nigeria
At Nibi Biopharma Limited, we are at the forefront of Nigeria’s biopharmaceutical transformation, dedicated to producing vaccines and essential therapeutics at global quality standards. Our mission is to reduce dependency on imports, ensure self-sufficiency in pharmaceutical production, and contribute to Nigeria’s healthcare resilience.
As part of the Nibi Biopharma Project, we are establishing a world-class biopharmaceutical industrial complex designed to become the largest, lowest-cost, and highest-quality manufacturer in West and Central Africa. With a focus on innovation, efficiency, and sustainability, Nibi Biopharma Limited is positioned to double Nigeria’s local manufacturing capacity while delivering affordable, accessible, and life-saving biopharmaceuticals.
At Nibi Biopharma Limited, we are not just manufacturers; we are shaping the future of biopharmaceuticals in Nigeria and beyond
Commitment to Excellence & Global Standards
Our facilities are designed to meet Good Manufacturing Practices (GMP), WHO, and international regulatory standards, ensuring that every product we manufacture adheres to the highest levels of safety, efficacy, and reliability.
Our production capabilities include:
- 250 million doses per year of routine immunization vaccines
- 100 million doses per year of novel vaccines (e.g., malaria)
- 5 billion tablets and 600 million capsules of essential therapeutics
- State-of-the-art infrastructure, including a 20MW captive power plant and a 150 million-liter-per-year water treatment facility
Through rigorous quality control, biosecurity compliance, and advanced manufacturing processes, we are committed to delivering biopharmaceuticals that meet global health standards while ensuring long-term sustainability.
Excellence is not just a goal at Nibi Biopharma Limited, it is the foundation of everything we manufacture.
250+ Million
Doses per year of routine immunization vaccines.
100 Million
Doses per year of novel vaccines (e.g., malaria)
50K+ Sq. Ft.
State-of-the-art manufacturing space dedicated to innovation in biopharmaceutical production.
A Vision for the Future
Nibi Biopharma Limited is not only focused on current production needs but also on expanding Nigeria’s role in the global biopharmaceutical industry. Our Phase 2 development will include:
- Production of Active Pharmaceutical Ingredients (APIs) for essential therapeutics
- Manufacturing of biologics, including insulin and plasma-derived products
- Development of antigens for vaccine production
By building capacity, creating jobs, and securing local pharmaceutical production, Nibi Biopharma Limited is paving the way for a self-sufficient, innovation-driven biopharmaceutical ecosystem in Nigeria.
